Table 5 Baseline features of the trials included
Trial name | Mean age | Males (%) | Ht (%) | Ds (%) | Cs (%) | DM (%) |
|---|---|---|---|---|---|---|
ZES/EES | ZES/EES | ZES/EES | ZES/EES | ZES/EES | ZES/EES | |
DUTCH PEERS [17] | 64.0/65.0 | 73.0/73.0 | 55.0/53.0 | 46.0/48.0 | 24.0/26.0 | 18.0/17.0 |
HOST-ASSURE [18] | 63.5/63.1 | 65.6/69.8 | 68.1/68.2 | 65.7/64.0 | 29.5/32.9 | 32.0/31.8 |
Lin 2015 [15] | 63.0/65.5 | 72.8/73.4 | 71.9/69.6 | 59.3/57.4 | 64.8/51.4 | 25.5/25.2 |
Mehilli 2013 [16] | 69.4/70.2 | 72.8/77.3 | 68.2/69.9 | 68.8/75.8 | 14.8/13.2 | 28.4/28.5 |
RESOLUTE [19] | 64.4/64.2 | 76.7/77.2 | 71.1/71.3 | 63.9/67.7 | 26.5/26.5 | 23.5/23.4 |
TWENTE [20] | 63.9/64.5 | 72.5/72.5 | 55.4/55.8 | 57.0/61.4 | 25.3/23.6 | 22.7/20.6 |